Microcap cardio player touts a ‘sizable’ tech deal with Bayer’s BlueRock in wake of ‘going concern’ alert

A microcap biotech player operating under a “going concern” alert is touting a tie-up with Bayer’s BlueRock, a high-profile outfit exploring the frontiers of cell therapy R&D. Sunnyvale, CA-based BioCardia says it nabbed a “sizable” upfront in the pact, which will put a catheter-based system it devised to deliver a…

...

Click to view original post